Viewing nowCombinationTelmisartan 80/2.5 mg (Telmisartan, Esanmolodipine Besylate Dihydrate)
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 201302980 · Approved 2013.01.31 · Insurance code 643306540
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower and manage blood pressure in patients with essential hypertension where blood pressure is difficult to control with monotherapy of Telmisartan or Esanmolodipine.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the doses of the individual components (telmisartan or S-amlodipine (amlodipine)) be adjusted. However, if blood pressure is not adequately controlled with an individual component, switching directly to this medicine may be considered as follows: - 40/2.5 milligrams: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or telmisartan 40 milligrams. - 80/2.5 milligrams: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 40 milligrams or 80 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 80 milligrams or this medicine 40/5 milligrams. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ◦ Patients with renal impairment: No dose adjustment is needed for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended that treatment be started at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients in whom this medicine should be used with caution'). For elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, particularly during the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. Additionally, patients with allergies to the ingredients of this medication or those with specific heart diseases, liver dysfunction, hypotension, or renal failure should avoid taking this medication. Side effects such as dizziness, headache, swelling, and dyspepsia may occasionally occur, so if any abnormal symptoms occur, consult a doctor. Since this medication lowers blood pressure, there is a risk of hypotension, and caution is needed particularly in patients with insufficient body fluids or salts. There is a risk of elevated potassium levels, so consult a doctor if taking potassium supplements or medications containing potassium. Patients with impaired renal function should have their kidney function monitored regularly while taking this medication. Interactions may occur if taken with other blood pressure medications or specific drugs, so if you are taking other medications, be sure to inform your healthcare provider. Dizziness or drowsiness may occur when driving or operating machinery, so caution is advised. Elderly patients or those with heart disease should take this medication with extra caution, and dose adjustments may be necessary. In cases of overdose, severe hypotension, dizziness, and heart problems may occur, so the dosage must be strictly adhered to, and any abnormal symptoms should be reported to medical personnel immediately.
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to air and moisture, so it should be stored in a tightly closed container. Additionally, it is recommended to store it at room temperature between 1 and 30 degrees Celsius, avoiding extremes of hot or cold.
Egg-shaped tablets consisting of two layers of light yellow and light blue
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Healthcare Co., Ltd.
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
BC World Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.